Shopping Cart
- Remove All
Your shopping cart is currently empty
CCR4 antagonist 2 (Compound 31) is a novel, potent, orally bioavailable small molecule antagonist of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues. CCR4 antagonist 2 (Compound 31) exhibits IC50 values of Ca2+ flux and [chemotaxis] CTX at 40 nM and 70 nM, respectively.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | |
| 100 mg | Inquiry | 3-6 months |
| Description | CCR4 antagonist 2 (Compound 31) is a novel, potent, orally bioavailable small molecule antagonist of CC chemokine receptor 4 (CCR4) that inhibits Treg trafficking into the Tumor Microenvironment without suppressing the number of Treg in healthy tissues. CCR4 antagonist 2 (Compound 31) exhibits IC50 values of Ca2+ flux and [chemotaxis] CTX at 40 nM and 70 nM, respectively. |
| Targets&IC50 | Ca2+ flux:40 nM , CTX/CCR4:70 nM |
| Molecular Weight | 511.45 |
| Formula | C26H28Cl2N6O |
| Cas No. | 2206788-99-8 |
| Relative Density. | 1.44 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.